Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro
- PMID: 10421427
- DOI: 10.1016/s0024-3205(99)00262-3
Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro
Abstract
The aim of the present work was to study whether melatonin, at physiological concentrations, exerts its antiproliferative effects on MCF-7 human breast cancer cells by inducing the expression of some of the proteins involved in the control of the cell cycle. MCF-7 cells were cultured for 48 h in DMEM media containing either melatonin (1 nM) or the diluent (0.001% ethanol). At this concentration, after 48 hours of incubation, melatonin reduced the number of viable cells in relation to controls. The decreased cell proliferation was coincident with a significant increase in the expression of p53 as well as p21WAF1 proteins. These results demonstrate that melatonin inhibits MCF-7 cell proliferation by inducing an arrest of cell cycle dependent on an increased expression of p21WAF1 protein, which is mediated by the p53 pathway.
Similar articles
-
Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?J Pineal Res. 2002 Mar;32(2):90-6. doi: 10.1034/j.1600-079x.2002.1821.x. J Pineal Res. 2002. PMID: 12071473
-
Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.Int J Oncol. 1998 Apr;12(4):793-804. Int J Oncol. 1998. PMID: 9499438
-
Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.Oncol Rep. 2001 Sep-Oct;8(5):1091-6. doi: 10.3892/or.8.5.1091. Oncol Rep. 2001. PMID: 11496322
-
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.Int J Oncol. 2004 Mar;24(3):591-608. Int J Oncol. 2004. PMID: 14767544
-
Melatonin and mammary cancer: a short review.Endocr Relat Cancer. 2003 Jun;10(2):153-9. doi: 10.1677/erc.0.0100153. Endocr Relat Cancer. 2003. PMID: 12790777 Review.
Cited by
-
New Prophylactic and Therapeutic Strategies for Spinal Cord Injury.J Lifestyle Med. 2013 Mar;3(1):34-40. Epub 2013 Mar 31. J Lifestyle Med. 2013. PMID: 26064835 Free PMC article. Review.
-
Melatonin as a potential inhibitory agent in head and neck cancer.Oncotarget. 2017 Aug 9;8(52):90545-90556. doi: 10.18632/oncotarget.20079. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163852 Free PMC article. Review.
-
Molecular mechanisms of melatonin's inhibitory actions on breast cancers.Cell Mol Life Sci. 2013 Jun;70(12):2139-57. doi: 10.1007/s00018-012-1161-8. Epub 2012 Sep 25. Cell Mol Life Sci. 2013. PMID: 23007844 Free PMC article. Review.
-
Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.Oncotarget. 2016 Apr 12;7(15):20532-48. doi: 10.18632/oncotarget.7978. Oncotarget. 2016. PMID: 26967561 Free PMC article.
-
Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Int J Mol Sci. 2017 Jun 7;18(6):1221. doi: 10.3390/ijms18061221. Int J Mol Sci. 2017. PMID: 28590419 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous